gener pharma takeaway
global apparel specialti
updat loan week
constraint improv
med-tech takeaway tvt summari
full comment requir non-u analyst conflict disclosur
pleas click link
flare water initi coverag sector perform
evalu upsid re-rat near complet
adjust estim reflect jlt acquisit
eha updat keep ultomiri pedest doesnt appear match efficaci
yd island site visit year transit set free cash flow
note execut execut execut
learn eu/igba confer investor sentiment
prelud
week june
tool hand unicredit re-rat acceler non-cor rundown
eha takeaway ophtho kol call amgn herceptin biosim
price prior day market close estimate unless otherwis note
weekli perspect healthcar industri compani news valuat updat
week end june c-store space
midstream energi esg
news nashvil
pull pump retail
 of daili summari
 spak automak
specialti pharma
focus week
find research
insight www rbcinsightresearch com global research destin web contact capit market sale
repres access global research site
eu gener confer symphoni data teva weak
valu usd unless otherwis note
flare water initi coverag sector perform
rtlr close get public pure play permian water infrastructur
grow subsector increas competit believ rtlr key
advantag vs competitor tie top-tier sponsor contract
protect pricing/margin pressur valuat alreadi point
warrant view premium vs closest peer initi sector perform
price target
initi coverag sector perform price target
tie activ sponsor rattler corpor sponsor
top-tier permian produc gross leasehold acr
play guid run drill rig program complet
well think level activ focu
peco counti product area support volum growth rtlr
in-lin estim
contract differenti connect ipo rtlr enter
sever fixed-fe contract provid midstream servic
certain dedic acreag total acr delawar
midland basin respect
expand rattler current asset base signific capac absorb
minim capital-expenditure progress develop plan believ
level upsid rtlr exist asset base enabl partnership deliv
high roac gener posit free cash flow
valuat look fair valu rtlr sotp basi appli target multipl
rtlr busi area result impli ev/ebitda
evalu upsid re-rat near complet
year-to-d alac share materi outperform preciou metal peer
given success ramp-up sulfid project risk/reward proposit
balanc still see potenti share
price upsid sulfid project approach steadi state oxid life extend
balanc sheet de-lev reiter outperform
target fundament posit improv
increas target alac
reflect higher multipl stronger near-term forecast sulfid
oxid well assum mine-lif upsid oxid
continu de-risk sulfid post commerci product
reiter view manag done commend job deliv
expect date mitig risk ramp-up inher
market data cad financi data usd
risk remain elev steadi state result demonstr consist
believ creat potenti upsid alac maintain
posit momentum result to-dat encourag steadi
improv util throughput recoveri perform
near design level may
free cash flow ultim test success
alac cash gener impress especi earli ramp-
analysi past invest cycl demonstr strong trend
out-performance follow inflect posit well willing
investor pay premium strong margin
low-hang fruit add valu oxid
market focu directli tie sulfid project believ
on-going oper out-performance oxid potenti mine life
extens larg overlook investor along increas
product back improv guidanc also incorpor
potenti mt leach pad expans includ assum develop ardich
well modest on-going near-pit explor success
adjust estim reflect jlt acquisit
follow file disclos inform jlt pro-forma
revenu fold jlt estim estim reflect
modest dilut origin expect remain construct long-
term merit jlt acquisit
valu usd unless otherwis note
estim revis ep estim
incorpor jlt estim previou estim
includ jlt assumpt repres reduct
estim although still forecast ep growth margin expans
ex amort year estim adjust reflect season
jlt result particular tend jlt season weakest quarter
compani unprofit typic highest revenu
quarter tend season strongest ep estim
price target rais price target
equat ep ebitda/shar estim previou
multipl base prior ep ebitda/shar
estim slightli higher multipl reflect higher sector valuat
assumpt assum quarterli interest expens million
well addit million amort per quarter result
jlt transact assum share buyback would
look updat capit alloc thought call expect
debt reduct part fold anticip
top-lin disrupt evid jlt result next quarter
expect deal size
valu usd unless otherwis note
market data usd financi data usd dividend paid
eha updat keep ultomiri pedest doesnt appear match
today eha roch partnership chugai present long-term
safeti efficaci data antibodi igg open
label extens ole compos part studi pnh
patient compos patient complement nave wherea
compos patient previou soliri exposur
subcutan administr inhibitor treatment pnh
emerg competitor alxn ultomiri whose subcutan program
year ahead develop advanc studi guid
potenti market launch pnh ahu file expect
individu longitudin patient data set suggest earli sign
efficaci compar ultomiri result remain variabl small data
set total patient follow-up differ dose schedul pk/
pd profil patient support sc dose qw patient
maintain minimum plasma level drug g/ml notabl mean
hemoglobin level stabil mean level stabil
g/l week termin marker complement activ ldh
maintain low level suggest sustain treatment effect
break-through hemolysi report extens phase
reduc ldh level uln uln uln
wk studi
friday eular present updat open-label data on-going studi
lenabasum system sclerosi ssc dermatomyos dm
ssc data week continu look promis criss score though
note compon improv appear slow
addit present ph ii studi illustr detail around
formal calcul methodolog acr criss weight
compon present construct acr criss score
calcul avail upon request
updat dm data show continu improv cdasi score
week toler safeti profil ph iii placebo-control readout
expect follow ssc ph iii
underli beer busi remain healthi compani immun
poor weather plagu much quarter lower
beer deplet estim previous distributor work suggest
dynam entir driven weather long-term thesi remain
takeaway beer distributor survey distributor survey work point
deplet growth quarter survey respond notic
improv consum spend major survey particip
point promot environ line expect
suggest environ less year ago distributor said
premier perform expect respond significantli
expect respond line expect
encouragingli distributor suggest premier cannib
corona/corona lower expect in-lin
expect higher expect distributor said
corona refresca perform line expect
respond wors expect expect
distributor said corona brand play spike seltzer space
wine spirit updat last month cfo david klein suggest
unlik low-end wine brand divestitur would close end
quarter given time lower net sale ebit growth
estim respect driven time shipment
chang model lower deplet estim
driven poor weather throughout quarter particularli may california
ep estim come in-lin consensu
price target remain unchang
valu usd unless otherwis note
valu usd unless otherwis note
yd island site visit year transit set free cash flow
alamo host tour ontario asset highlight expect improv
result young-davidson on-going upsid island on-going investor
focu free cash flow gener believ alamo challeng
outperform peer tie-in lower mine young-davidson near
complet phase ii expans island execut kirazli project
success ramped-up expect reiter sector perform
product growth declin capit drive
alamo undergo year transit set product
growth number project complet includ
complet lower mine tie-in young-davidson construct
kirazli project turkey cerro pelon project mexico anticip
come on-line end result expect free cash flow
inflect ramp versu averag
neg gener
young-davidson oper inflect point horizon
expect young-davidson start demonstr true long-term potenti
follow tie-in lower mine remain track
expect drive materi growth free cash flow given stronger product
lower cost declin capit intens overal lower mine design
greater product expect allow throughput reach tpd
tpd upper mine drive unit mine cost
island execut phase ii decis phase await
island gold becom cornerston asset alamo deliv strong
improv oper result well impress explor result expect
oper rate island increas tpd current run-rat
tpd note mine infrastructur mill alreadi capac
tpd manag alreadi begun evalu potenti phase
expans result expect earli
note execut execut execut
continu believ invest offer investor opportun
achiev cycl averag return compani posit
grow commerci bank busi key industri vertic
recent acquisit laurel potenti meaning grow
consum bank busi digit channel
took chri gorman vice chairman presid bank kimbl
vice chairman chief offic vern patterson vice presid
investor relat eu/uk visit institut investor overal
tone convers posit investor inquir gener
outlook affect recent declin long term interest rate
net interest margin nim outlook credit qualiti
valu usd unless otherwis note
modestli adjust estim adjust non-recur revenu
march quarter slightli conserv view fx impact
updat estim account certain non-recur revenu
prior quarter revenu base conserv view fx
revenu previou
estim ebitda previou ebitda
previou
valu usd unless otherwis note
valu usd unless otherwis note
valu usd unless otherwis note
valu usd unless otherwis note
valu usd unless otherwis note
averag sell price domest same-deal sale use class truck
y/i flat m/m may volum declin m/m accord act
research preliminari data releas friday close class class
truck also saw higher y/i price lower volum
use class truck price surprisingli strong y/i basi like due
part extend new truck backlog howev note may y/i increas
smallest last year comp start stiffen also
expect rise new use truck suppli begin weigh valuat
remain sector perform-r commerci vehicl relat coverag
includ allison transmiss wabco
lead coverag capit market llc auto analyst spak
valuat tabl power price frac spread data rel price perform
gener pharma takeaway europ
learn eu/igba confer investor sentiment
spent last week half road meet investor europ
follow attend particip annual medicin europ
intern gener biosimilar medicin associ confer
warsaw poland preview meet june gener pharma closer look
teva/myl ou expect eu/igpa confer question
ask includ closer look eu/row busi teva
see exhibit overal divers mix corpor represent teva
valu usd unless otherwis note
valu usd unless otherwis note
valu usd unless otherwis note
execut panel limit street attend investor
meet limit gener long interest confer attend came shortli
publish june report gener pharma primer
new environ deep dive look new gener realiti lower price
target topic meet continu stock volatil short
pressur group continu link
global apparel specialti softlin
prelud
follow tough earn season includ reduc outlook stock
averag ytd vs convers investor
late center whether strength perfect storm
strong consum ideal weather open capac store closures/
bankruptci earli sign fashion trend extens lead
whether result indic underli norm lesser
visibl given lack busi momentum broadli
softlin typic model see return hockey
stick outlook june/juli improv embed outlook
june cooler wetter backdrop ty greater risk estim could
inventori carryov given gross expans target back half
see signific valuat disconnect select name despit
underli earn compound stori end favorit name order
includ goo rl base client convers see
interest goo lb rl
updat estim updat ep
reflect buyback ep move
pt remain updat
model exclud ep
pt move appli updat ep
updat loan week
weekli industri loan non-season adjust loan
week-over-week w/w basi end june year-over-
year y/i basi follow trend
commerci industri w/w y/i
consum w/w y/i
commerci estat w/w y/i
residenti estat w/w y/i
equiti w/w y/i
w/w y/i
hard disk drive updat cpu constraint improv
take-away updat hdd model introduc
estim well given volatil unit due hyperscal spend paus
cpu constraint start year think unit could similar
due easier comparison demand uptick hyperscal
overal view unit flattish like materi
valu usd unless otherwis note
valu usd unless otherwis note
mid-teen lower revenu perspect low-doubl digit net
net estim call unit think investor anticip
unit estim unit think
week june
thought lower interest rate interest rate fall
sever month think reach point life insur investor
need pay attent comment topic relat interest rate sensit
watch concern respect credit qualiti
behavior balanc sheet impact awar also
discuss impact compani think question
compani exposur dont rather question one
whether valuat suffici embrac exposur
earli wildfir outlook past week nation interag fire
center june wildfir preview averag earli
season wet reduc drought condit california much
west coast wet allow growth set forecast
averag season southern california above-averag wildfir season
steadi growth voluntari benefit walk voluntari benefit
data show premium growth across key line voluntari
benefit last year growth voluntari benefit good
place past year believ margin outlook voluntari
benefit good long economi stay solid foot
solid premium growth year
tool hand unicredit re-rat acceler non-cor rundown
despit ucg out-performance isp year date continu see
substanti upsid reiter top pick rate ucg pt
previous sector perform rate pt
previous continu appreci posit
cost disciplin improv asset qualiti high dividend lower longer
interest rate environ see isp option off-set continu margin
pressur somewhat limit contrast ucg nii footprint offer
support nii term loan growth margin off-set due mix
chang manag deliv well cost believ
addit believ acceler non-cor run-off could
meaning rerat share
chines market excav unit sale decreas y/i may ytd y/i
first y/i declin sinc februari
two year signific expans growth expect slow
although recent outlook improv
earlier view report project increas construct
equip market prior flattish estim declin industri
sale excav prior declin
caterpillar may unit sale decreas y/i unit accord cmbol
market leader sani saw may unit sale increas
valu usd unless otherwis note
valu usd unless otherwis note
caterpillar may share drop prior-year period
expand april m/m increas push third place
behind sani y/i xcmg y/i
week review biotech coverag univers end week
vs nbi ytd vs
nbi notabl end week
continu ralli last week gain link bear thesi note link
last weekli remain one prefer smid-cap biotech name
ahead oraxol oral paclitaxel data expect august
med-tech takeaway tvt
tvt featur updat sever investig devic tavr tmvr
among tavr portico centera next-gener system
respect evolut lotu platform featur tmvr
receiv updat trial intrepid tendyn
mdt apollo trial intrepid tmvr make good progress far
site activ perform tmvr intrepid
patient consent trial patient accept fewer
one three patient
abt summit trial tendyn tmvr hold trial design review
follow approv mitraclip secondari mitral regurgit unlik
apollo trial summit trial exclud patient primari mr
use cerebr protect devic cep like sentinel remain topic
intens debat favor use cep everi tavr procedur argu
despit low rate stroke observ random clinic trial
stroke rate observ tavr registri declin oppon cite cost
lack conclus data
midstream energi esg energi golden
accord mckinsey trillion one-quart asset
manag global invest accord esg environment social
govern factor european asset manag lead
trend becom preval us forum sustain
respons invest estim sustain invest us grew
public fund insur compani particularli
believ midstream compani take advantag grow trend
widen investor base enhanc esg practic
main consider variou esg indic ftse stoxx
high esg rate among sector peer larg market capit subsector
low volatil high dividend yield commonli exclud sector
alcohol tobacco gambl civilian firearm weapon nuclear power adult
entertain
top esg-perform midstream includ indic
disclosur data first step inclus consequ look
